Adaptive Biotechnologies ADPT Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's accounts payable?
- Adaptive Biotechnologies (ADPT) reported accounts payable of $9.62M in Q1 2026.
- How has Adaptive Biotechnologies's accounts payable changed year-over-year?
- Adaptive Biotechnologies's accounts payable increased by 51.1% year-over-year, from $6.36M to $9.62M.
- What is the long-term trend for Adaptive Biotechnologies's accounts payable?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's accounts payable has grown at a 14.8% compound annual growth rate (CAGR), from $3.24M to $6.47M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.